The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
The role of 5-HT receptors in depression
Open accessAbstract
Depression is a polygenic and highly complex psychiatric disorder that remains a major burden on society. Antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), are some of the most commonly prescribed drugs worldwide. In this review, we will discuss the evidence that links serotonin and serotonin receptors to the etiology of depression and the mechanisms underlying response to antidepressant treatment. We will then revisit the role of serotonin in three distinct hypotheses that have been proposed over the last several decades to explain the pathophysiology of depression: the monoamine, neurotrophic, and neurogenic hypotheses. Finally, we will discuss how recent studies into serotonin receptors have implicated specific neural circuitry in mediating the antidepressant response, with a focus being placed on the hippocampus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the effects of serotonin receptors have been linked to antidepressant effects(Yohn et al., 2017)”
From Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysis (2024) · cites this paper as Yohn et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
da Luz, A. C. D. D. S., Dias, G. P., Bevilaqua, M. C. D. N., Cocks, G. D., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 4,015
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,588
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Research works printed but not linked: 1
- Feighner JP, Boyer WF. Selective serotonin reuptake inhibitors, 2nd edition: advances in basic research and clinical practice. Chichester: Wiley; 1996.
Cited by
Sorted by citations
Items 401–489 of 489
Михайленко, В. А., & Буткевич, И. П. (2018) · Журнал эволюционной биохимии и физиологии · doi:10.7868/s0044452918040099
Saiz-Bianco, E., Urbanavicius, J., Prunell, G., & Lagos, P. (2019) · Neuropeptides · doi:10.1016/j.npep.2018.12.005
Budylin, T. (2019) · CUNY Academic Works (City University of New York)
Patel, S. H. (2020) · ODU Digital Commons (Old Dominion University)
Li, J., Lü, W., Huang, W., Wu, S., Fu, Y., Chen, J., Huang, Z., Zhou, X., & Wang, H. (2021) · Acupuncture & Electro-Therapeutics Research · doi:10.3727/036012921x16287835103444
Puberty and Affective Mental Illness in Males
Herbert, J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108646765.005
Verma, V., Banerjee, B., & Mehta, A. K. (2021) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20212067
Rangaswamy, S., Saklani, M., Kumar, R., Mathur, R., Kaul, A., Tiwari, A. K., Kaur‐Ghuman, S., Mishra, A. K., & Varshney, R. (2021) · ChemistrySelect · doi:10.1002/slct.202100549
Oh, D.-R., Kim, Y., Oh, K.-N., Kim, Y., & Bae, D. (2021) · Annual Research & Review in Biology · doi:10.9734/arrb/2021/v36i630387
İleri Yaş Depresyonunda Farmakogenetik Yaklaşımlar
Özbey, G., ÖZKOÇ, C., ÖZKAN, Y. E., & SAKA, K. K. (2021) · Akdeniz Medical Journal · doi:10.53394/akd.957675
Mncube, K. (2021) · Boloka Institutional Repository (North-west University)
Plasma levels of neurotrophic factors are not associated with the severity of depression
Zorkina, Y., Syunyakov, T., Abramova, O. V., Yunes, R. А., Pavlichenko, A. V., Ka, P., Khobta, E. B., Susloparova, D. A., Tsarapkin, G. Y., Andreyuk, D., et al. (2021) · Consortium Psychiatricum · doi:10.17816/cp110 · Cited by 1
Merino, P. (2019) · Wiley eBooks · doi:10.1002/9783527813421.ch3
Almughamis, A. (2022) · Family Medicine and Primary Care Open Access · doi:10.29011/2688-7460.100075
Rashid, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-67123-5_44
Movement Disorders Associated With SSRIs
Goldman, J. G., & Galicia, C. M. G. (2022) · doi:10.1093/med/9780197574317.003.0007
Hashmi, T. S., Tazarrat, A., Muzafar, S., Ashfaq, S., Anwar, I., & Kiran, N. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22167845
Mukherjee, S., & Ray, S. K. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220811092906
Singh, R. K., Choudhary, N. K., & Kharia, A. A. (2022) · Asian Pacific Journal of Health Sciences · doi:10.21276/apjhs.2022.9.4s1.39
Nagdeo, K. P., Midya, V., Lane, J. M., Torres-Olascoaga, L. A., Martínez, G. G., Horton, M. K., Gennings, C., Téllez‐Rojo, M. M., Wright, R. O., Arora, M., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3342709/v1
Kiyokawa, Y., Ootaki, M., Kambe, Y., Tanaka, K., Kimura, G., Tanikawa, T., & Takeuchi, Y. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4635802
The Association Between Short Sleep Duration and Depressive Symptoms Among Elderly Farmers
Song, S. W., Lee, H. J., Yoo, J. R., & Oh, J.-H. (2023) · Journal of Sleep Medicine · doi:10.13078/jsm.230024
The Neuroanatomy, Etiopathogenesis, and Novel Therapeutic Targets in Depressive Disorders
Arora, I., Khurana, K., & Kumar, M. (2024) · Current Psychopharmacologye · doi:10.2174/0122115560281804240102054639
Midya, V., Nagdeo, K. P., Lane, J. M., Torres-Olascoaga, L. A., Martínez, G., Horton, M. K., Gennings, C., Téllez‐Rojo, M. M., Wright, R. O., Arora, M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3922286/v1
Psikofarmakoloji: Psikiyatri Hemşireleri Neleri, Neden Bilmeli?
Murat, M., & Küçük, L. (2024) · Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi · doi:10.31125/hunhemsire.1169736
Research Progress on the C-1019G Polymorphic Locus of 5-HT1A Gene
钟, 从. (2024) · Bioprocess · doi:10.12677/bp.2024.143021
Cruz, G., Fonseca, M., da Silva, R., Torres, R., & Rodrigues, J. M. (2024) · Revista Internacional de Acupuntura · doi:10.1016/j.acu.2024.100297
Anisman, H., Hayley, S. P., & Kusnecov, A. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.00006-5
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.09996-8
Association between 5-Htr Gene Polymorphism and Alcohol Use Disorder in Yunnan Han NationalityPreprint
Li, K., Wei, W., Wang, Y., Zhang, N., Bao, J., Zhang, X., Zheng, X., Zhao, F., Yang, X., Gao, C., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5061628
Li, K., Wei, W., Wang, Y., Zhang, N., Bao, J., Zhang, X., Zheng, X., Zhao, F., Yang, X., Peng, J., et al. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.01.008
Viral Reactivation After Stroke: A Novel Model for Post-Stroke DepressionPreprint
Walker, M., Zunt, J. R., Levitt, M. R., & Koelle, D. M. (2025) · medRxiv · doi:10.1101/2025.04.02.25325132
Anti-central fatigue effects of myelophil in 5-HTergic hyperactivity mice model
Kang, J.-Y., Baek, D.-C., Lee, J.-S., & Son, C. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04882-2
Ren, Q., Wang, Y., Han, X., Wang, Q., & Liang, G. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02567-w
Avula, V. C. R., Amalakanti, S., & Shashidhara, M. (2025) · Bengal Journal of Psychiatry · doi:10.25259/bjpsy_2_2025
Gene Expression in the Hippocampus
Taheri, S., & Abusalim, M. R. S. (2025) · Springer eBooks · doi:10.1007/978-3-031-88907-3_11
Whole body vibration alleviates depressive symptoms through its anti-inflammatory effects
Duan, Y., Xiong, L., Li, J., Jiang, J., Chen, Y., Zhou, J., & Li, T. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111690
Li, S.-J., Yuan, Q., Wu, W., Tan, A., Chen, Z., Chen, D., Shan, H., Chu, Q.-Y., Hu, W., Wu, K., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5343606
Poostiyan, N., Shahmoradi, Z., Shoushtarizadeh, M., Pordeli, M., & Montazeri, R. (2025) · Journal of Skin and Stem Cell · doi:10.5812/jssc-163664
Hepburn, H., Ellenbroek, B. A., & Youn, J. (2025) · Psychedelics · doi:10.1016/j.psyche.2025.100005
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583416
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583419
‘Shrooms for the Blues: Psilocybin to alleviate difficult-to-treat depression
Graham, Z. (2022) · Journal of High School Science · doi:10.64336/001c.37945
Yu, H., Shao, S., Xu, J., Guo, H., Zhong, Z., & Xu, J. (2022) · Figshare · doi:10.6084/m9.figshare.20012887
Ringleb, M., & Javelle, F. (2023) · OSF Preprints (OSF Preprints) · doi:10.17605/osf.io/guatx
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583413
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583422
Liu, Z. F., Sylivris, A., Gordon, M., & Sundram, S. (2022) · Figshare · doi:10.6084/m9.figshare.20454535
Li, B., Xu, J., Zhu, H., Ren, D., Xiao, L., Zhang, T., & Li, R. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110844
A structural overview of G-protein-coupled receptors in neurological disorders
Gupta, O. D., Chakraborty, I., & Pal, K. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01712-6
Lin, M., Chen, X., Wu, N., Xiao, R., Gong, Y., Liu, M., & Qin, T. (2026) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2026.01.006
Translational reprogramming of dentate gyrus peptidergic circuitry gates antidepressant efficacy
Oh, S.-J., Jang, J.-H., Roussarie, J.-P., Jang, G.-U., Jeong, M.-S., Jo, Y. S., Shin, C.-H., Choi, H., Lee, K., Yoon, J. H., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03461-2
Wang, X., Huang, Y., Si, H., Li, Y., Yu, J., Zhou, W., Chen, H., & Wang, C. (2026) · Aging & Mental Health · doi:10.1080/13607863.2026.2642780
Le récepteur 3 de la neurotensine/Sortiline dans la régulation de l’état dépressif
Moréno, S. (2017) · theses.fr (ABES) · doi:10.70675/bd5432bcz3426z4e54z9081zd99b2eb3f712 · Cited by 1
Potentialisation de la réponse antidépressive par la lumière : étude préclinique
Delcourte, S. (2019) · theses.fr (ABES) · doi:10.70675/7468b6d3zbf12z4888z88afzc63efcc91723
Le récepteur 5-HT6, une nouvelle cible pour le traitement des douleurs neuropathiques
Martin, P.-Y. (2018) · theses.fr (ABES) · doi:10.70675/07f1c1dcz43f2z4752zbafcz43480dae7825
Piétri, M. (2019) · theses.fr (ABES) · doi:10.70675/3122d414zcceez468bz8e31z83d8dba42e33
Exploring the molecular determinants of behavioral changes induced by ketamine at the nanoscale
Uyttersprot, F. (2024) · theses.fr (ABES) · doi:10.70675/df438baaz92d0z488aza38cz4227b46c9acb
Huan, G., Wang, S., Liu, Q., Jia, J., Yang, Y., & Jin, Z. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111009
Chawla, G., Pradhan, T., Alam, N., Kunzang, S., & Gupta, O. (2026) · Archiv der Pharmazie · doi:10.1002/ardp.70251 · Cited by 1
Molecular Aspects of Depressive Disorders
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_8
Cognitive Dysfunction and Suicide
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_19
Han, B., Wang, Y., Yang, Z., Chen, Y., Huang, X., Zhang, X., Wang, H., & Zeng, X. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158368
Xiang, M., Wang, H., Dai, Y., & Yu, L. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1846281
Lampada, A., Rolando, C., Whittle, N., Engler, A., Tillmann, J. F., Freire, J. A., Giachino, C., Parmigiani, E., Saotome, I., Louvi, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed3625
Medicinal chemistry advances of TAAR1 agonists: SAR, structural innovation, and mechanistic insights
Zhang, W., Wu, W., Gao, J., Xian, J., Yao, Y., Liao, W., Zhang, J., & Wang, Y. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119058
Vestibular disorders and monoamine neurotransmitters: Current evidence
Liu, Y., Zhou, L., Chen, X., Tian, E., Lu, Y., Wu, P., Zhang, S., & Wang, J. (2026) · iScience · doi:10.1016/j.isci.2026.116401
Zhao, X., Xiao, S., Ma, X., Qi, Y., Liu, Z., Xu, X., Chang, C., Wu, J., Gong, Z., Shao, B., et al. (2026) · Food Research International · doi:10.1016/j.foodres.2026.119908 · Cited by 1
Cáceres, F., Díaz, A. H., Rincón, E., & Chamorro, E. E. (2026) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-026-00872-9
Gonela, U. M., Bricker, B. A., Voshavar, C., Onyameh, E. K., Adzimah, M. E., Kuudaar, E. B., Morgan, A., Jones, I. L., Tellis, E. W., & Ablordeppey, S. Y. (2026) · ACS Omega · doi:10.1021/acsomega.6c02255
Zolmitriptan ameliorates memory impairment secondary to depression via 5-HT-1B/1D receptors
Afzal, A., Batool, Z., Rafiq, S., Agha, F., Nawaz, A., & Haider, S. (2026) · Next research. · doi:10.1016/j.nexres.2026.102204
McIntyre, R. S., Kato, M., Thase, M. E., Therrien, F., Marrache, A. M., Ikehara, K., Ardic, F. C., & Boucher, M. (2026) · CNS Drugs · doi:10.1007/s40263-026-01315-7
Cahill, J. D., & Gallagher, K. (2026) · Cambridge University Press eBooks · doi:10.1017/9781108689229.010
Prescribers in the Era of Neuroscience
Miller, C. W. T., & Kvarta, M. D. (2026) · Cambridge University Press eBooks · doi:10.1017/9781108689229.031
Kankaynar, M., Ceyhun, H. A., Sulukan, E., Yıldırım, S., Şenol, O., Atakay, M., Baran, A., Bolat, İ., Salih, B., & Ceyhun, S. B. (2026) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2026.2716667
Liu, X., & Guo, Z. (2026) · Depression and Anxiety · doi:10.1155/da/8792696
Samina, M. C. F., Stanciu, M., Merkelijn, T., Garcia, L. P., Hanswijk, S. I., Witteveen, J. S., Alenina, N. V., Bäder, M., Homberg, J. R., & Kolk, S. M. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00382
BindingDB Entry 50008859: New dual ligands for the D
BindingDB (2021) · UC San Diego · doi:10.7270/q24b34qh
Qin, Z., Lei, T., Yi, T., Zhang, S., Tang, Y., Xiang, Y., Zhou, Z., Mei, Z., Qiu, F., & Zhang, X. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03948-y
Metadata
- Authors
- Yohn, C. N., Gergues, M. M., & Samuels, B. A.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Samuels, Benjamin Adam
- Venue
- Molecular Brain
- Published
- 2017-06-24
- Volume
- 10
- Issue
- 1
- Pages
- 28-28
- ISSN
- 1756-6606 (ISSN-L)
- PMC
- PMC5483313
- OpenAlex
- W2695471189
- Cited by
- 485
- References
- 190
- Citations by year
- 2026: 28 · 2025: 53 · 2024: 69 · 2023: 72 · 2022: 60 · 2021: 75 · 2020: 59 · 2019: 38 · 2018: 26 · 2017: 5
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Molecular Brain (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Brain and Behavior Research Foundation (NARSAD Young Investigator)
- National Institute of Mental Health (R01 MH112861)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- depression, serotonin receptors, serotonin, selective serotonin reuptake inhibitors, antidepressant response, monoamine hypothesis, neurotrophic hypothesis, hippocampus, neural circuits, depression pathophysiology
- MeSH terms
- Animals, Depression, Hippocampus, Humans, Models, Biological, Receptors, Serotonin, Serotonin, Neurogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review